These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 292979)
1. A pharmacotherapeutic rationale for the use of lithium carbonate in Tourette's syndrome. Messiha FS Proc West Pharmacol Soc; 1979; 22():27-9. PubMed ID: 292979 [No Abstract] [Full Text] [Related]
2. Lithium carbonate in Gilles de la Tourette's disease. Messiha FS; Erickson HM; Goggin JE Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):609-12. PubMed ID: 1069354 [No Abstract] [Full Text] [Related]
3. Biochemical pharmacology of Gilles de la Tourette's syndrome. Messiha FS Neurosci Biobehav Rev; 1988; 12(3-4):295-305. PubMed ID: 3067157 [TBL] [Abstract][Full Text] [Related]
4. Gilles de la Tourette's syndrome: biochemical approaches. Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064 [TBL] [Abstract][Full Text] [Related]
5. A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine. Hoge SK; Biederman J J Clin Psychiatry; 1986 Sep; 47(9):478-9. PubMed ID: 3462186 [TBL] [Abstract][Full Text] [Related]
7. Behavioral and clinical profiles of Tourette's disease: a comprehensive overview. Messiha FS; Carlson JC Brain Res Bull; 1983 Aug; 11(2):195-204. PubMed ID: 6414653 [TBL] [Abstract][Full Text] [Related]
8. The central role of magnesium deficiency in Tourette's syndrome: causal relationships between magnesium deficiency, altered biochemical pathways and symptoms relating to Tourette's syndrome and several reported comorbid conditions. Grimaldi BL Med Hypotheses; 2002 Jan; 58(1):47-60. PubMed ID: 11863398 [TBL] [Abstract][Full Text] [Related]
9. A study of endogenous dopamine metabolism in Gilles de la Tourette's disease. Messiha FS; Knopp W Dis Nerv Syst; 1976 Aug; 37(8):470-3. PubMed ID: 1066216 [TBL] [Abstract][Full Text] [Related]
10. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. Peterson BS J Clin Psychiatry; 1996; 57 Suppl 9():24-34. PubMed ID: 8823347 [TBL] [Abstract][Full Text] [Related]
11. Tourette's syndrome: update. Freeman RD; Connolly JE; Baird PA Can Med Assoc J; 1984 Jun; 130(12):1554-7. PubMed ID: 6587930 [TBL] [Abstract][Full Text] [Related]
12. The effects of naloxone in Tourette's syndrome. Sandyk R Ann Neurol; 1985 Sep; 18(3):367-8. PubMed ID: 3863543 [No Abstract] [Full Text] [Related]
13. Tourette's disease: successful treatment. Bieren RE J S C Med Assoc; 1969 Jan; 65(1):7-8. PubMed ID: 5249506 [No Abstract] [Full Text] [Related]
14. Remission of tics with lithium therapy: case report. Hamra BJ; Dunner FH; Larson C J Clin Psychiatry; 1983 Feb; 44(2):73-4. PubMed ID: 6402503 [TBL] [Abstract][Full Text] [Related]
16. [Gilles de la Tourette's syndrome (author's transl)]. Chen HB Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1979; 12(4):213-6. PubMed ID: 299063 [No Abstract] [Full Text] [Related]
17. A followup of eighty patients with Tourette's syndrome. Bruun RD; Shapiro AK; Shapiro E Psychopharmacol Bull; 1976 Apr; 12(2):15-7. PubMed ID: 769020 [No Abstract] [Full Text] [Related]
18. Tourette's syndrome and treatment with clomipramine hydrochloride. Donahoe DH; Meador M; Fortune T; Llorena R W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522 [TBL] [Abstract][Full Text] [Related]